Therefore, this undesirable effect of Bcl9 deletion on tumour retention in the ApcMin model partially negates the beneficial effects of Bcl9 loss in curbing β-catenin-dependent neoplastic gene expression. This evidence concerns the gene BCL9 and neoplasm.